ProCE Banner Activity

The Impact of Quadruplet Therapy Incorporating CD38 Antibodies in Transplant-Eligible Patients With NDMM

Slideset

Download this slideset for a comprehensive review of the latest data on quadruplet therapy incorporating CD38 antibodies in the treatment of transplant-eligible patients with newly diagnosed multiple myeloma.

Released: June 11, 2024

Expiration: June 10, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi